Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

6P67

Crystal Structure of a Complex of human IL-7Ralpha with an anti-IL-7Ralpha 2B8 Fab

Summary for 6P67
Entry DOI10.2210/pdb6p67/pdb
DescriptorAnti-IL-7R 2B8 Fab heavy chain, anti-IL-7R 2B8 Fab light chain, Interleukin-7 receptor subunit alpha, ... (7 entities in total)
Functional Keywordsinterleukin-7 receptor extracellular dohmain, antibody 2b8 fab fragment, protein polymer, immune system
Biological sourceMus musculus (Mouse)
More
Total number of polymer chains12
Total formula weight296908.01
Authors
Walsh, S.T.R.,Kashi, L.,Kohnhorst, C.L. (deposition date: 2019-06-03, release date: 2019-09-04, Last modification date: 2024-10-23)
Primary citationHixon, J.A.,Andrews, C.,Kashi, L.,Kohnhorst, C.L.,Senkevitch, E.,Czarra, K.,Barata, J.T.,Li, W.,Schneider, J.P.,Walsh, S.T.R.,Durum, S.K.
New anti-IL-7R alpha monoclonal antibodies show efficacy against T cell acute lymphoblastic leukemia in pre-clinical models.
Leukemia, 34:35-49, 2020
Cited by
PubMed Abstract: Pediatric T cell acute lymphoblastic leukemia (T-ALL) cells frequently contain mutations in the interleukin-7 (IL-7) receptor pathway or respond to IL-7 itself. To target the IL-7 receptor on T-ALL cells, murine monoclonal antibodies (MAbs) were developed against the human IL-7Rα chain and chimerized with human IgG1 constant regions. Crystal structures demonstrate that the two MAbs bound different IL-7Rα epitopes. The MAbs mediated antibody-dependent cell-mediated cytotoxicity (ADCC) against patient-derived xenograft (PDX) T-ALL cells, which was improved by combining two MAbs. In vivo, the MAbs showed therapeutic efficacy via ADCC-dependent and independent mechanisms in minimal residual and established disease. PDX T-ALL cells that relapsed following a course of chemotherapy displayed elevated IL-7Rα, and MAb treatment is effective against relapsing disease, suggesting the use of anti-IL7Rα MAbs in relapsed T-ALL patients or patients that do not respond to chemotherapy.
PubMed: 31439943
DOI: 10.1038/s41375-019-0531-8
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.9 Å)
Structure validation

226707

數據於2024-10-30公開中

PDB statisticsPDBj update infoContact PDBjnumon